Paul A. Bondor

I'll research this attorney's background and practice.

Let me verify the tracked cases and check for PTAB/IPR experience.

Paul A. Bondor — Patent Litigation Practice Summary

Practice focus. Bondor is a first-chair patent trial lawyer at Desmarais LLP whose practice centers on jury trials in complex, technology-driven disputes, supplemented by trade secret, unfair competition, trademark, design patent, and technology-antitrust work. His technology range is broad rather than niche: computer processors and memory design, semiconductor manufacturing, networking and high-speed serial/display interfaces (DisplayPort), software, pharmaceuticals, and medical devices (interventional cardiology, wound treatment, RF ablation), with a mechanical/aerospace engineering background. He also has notable multinational litigation experience, including Dutch, German, and U.K. proceedings.

Side preference. Desmarais describes him as handling "scores" of patent disputes "for both plaintiffs and defendants," and he has produced headline results on both sides. Within the tracked case list he is weighted toward the defense (3 defendant appearances vs. 1 plaintiff), consistent with the firm's defense-heavy blue-chip and IP-licensing client base. That said, the tracked list is a small sample (4 appearances) and is not a reliable proxy for his overall split; public descriptions confirm substantial plaintiff-side and licensing monetization work as well.

Firm context. Bondor has spent most of his career at Desmarais-adjacent firms. After clerking for Judge Louis L. Stanton (S.D.N.Y., 1993–1995), he joined Kenyon & Kenyon (associate 1995–2001; partner 2001–2003), then moved to Kirkland & Ellis's New York IP litigation group as a partner (2004–2011) alongside John M. Desmarais. He left Kirkland to help found Desmarais LLP, where he is currently a partner. He serves as President of the New York Intellectual Property Law Association (2025–26 term, following a President-Elect term) and is ranked in Chambers USA and IAM Patent 1000.

Notable matters and outcomes.

• Alcatel-Lucent (Lucent Technologies) v. Microsoft — Bondor was on the Kirkland/Desmarais trial team that obtained a record $1.54 billion patent jury verdict in 2007, then a second Lucent-Microsoft verdict and judgment totaling $512 million. (The $1.54B verdict was later vacated on appeal.)
• XMTT, Inc. v. Intel — Led Intel's defense with Jeff Seddon; won summary judgment of noninfringement in D. Del. (Feb. 2023) on claim construction of "serial processor," defeating claims against nearly all Intel desktop/mobile CPUs since 2012; affirmed by the Federal Circuit on Dec. 4, 2024.
• OPEX Corp. (ITC) — Secured an across-the-board ITC win including an exclusion order, cease-and-desist order, and a 100% bond during review.
• Medical device jury trial — Verdict yielding a judgment over $42 million plus enhanced damages, prejudgment interest, and a 32% ongoing royalty.
• Tracked cases: General Video LLC v. Dell Inc. (W.D. Tex., Judge Albright) — defending Dell against DisplayPort standard-related patents, including stereoscopic image transport and serial-link encoding claims. Promotion In Motion, Inc. v. New Cibo Vita LLC (D. Del., Judge Connolly) — representing the Welch's fruit-snack maker on probiotic coated-confectionery patents; the parallel ITC Section 337 investigation (337-TA-1501) was instituted in May 2026 and the district case was stayed by stipulation in June 2026.

PTAB / IPR experience. I could not verify from available sources that Bondor regularly appears in IPR/PGR proceedings; his public profile emphasizes district court and ITC trials and Federal Circuit appeals rather than AIA trial practice. Two tracked Desmarais entries appear in the data as "Untitled case" and could not be resolved to identify a specific forum on the available record, so this point should be treated as unconfirmed.

Bar / education. J.D., University of Michigan Law School, 1993 (magna cum laude, Order of the Coif, Michigan Law Review); B.S.E. in mechanical and aerospace engineering, Princeton University, 1990. Admitted in New York (1994) and D.C. (1996), the Federal Circuit, and various district courts; registered to practice before the USPTO.

Note: All results above are sourced from Desmarais LLP and Kirkland & Ellis firm news, Best Lawyers, IP STARS, Martindale, docket records, and USITC/industry press. Verified outcome details for the medical device verdict and pharmaceutical settlement are as stated in the firm's own summary and were not independently confirmed via court records.